Vitasora Health Limited has released a press release.
SaaS model & First 500 devices
Filed with ASX ·
6ix hasn’t read this filing yet.
Vitasora Health Limited on 6ix
Earlier from Vitasora Health
- CE Mark, manufacturer & clinical study agreement
- Chairmans Address to Shareholders
- Director and CEO Appointment
- Change of Chairman
- Update regarding departure of CEO
Later from Vitasora Health
- Cancellation of shares and options
- FDA submission to be lodged
- FDA update
- First batch of wheezos delivered
- Placement - investor presentation
Follow Vitasora Health into a list and get an email when it puts out news.
Follow Vitasora Health